Envista Holdings Corporation

NVST Healthcare Medical Instruments & Supplies

Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024.

Revenue
+3.22%
EPS
+1,855.6%
Free cash flow
−6.48%
Total debt
−1.13%

Quarter to September 2026, against a year earlier

24.98 2.21 −8.13%
Market cap
$4.0B
P/E
6.4×
Fwd P/E
21.5×
Dividend yield
—
F-score
7/9
Altman Z
1.59
Beneish M
−2.50
Dividend safety
n/a

Envista Holdings Corporation (NVST) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Envista Holdings Corporation (NVST) trades at a EV/EBITDA of 10.3×. Over the past ten years it has ranged from 0.0× (June 2025) to 46.3× (December 2020); the current reading is higher than 20% of that period. That is below the Medical Instruments & Supplies industry median of 14.9× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 10.8× —
FY2024 0.0× —
FY2023 23.1× 78.04%
FY2022 13.0× (16.68%)
FY2021 15.6× (45.46%)
FY2020 28.6× 124.11%
FY2019 12.8× —
FY2018 0.0× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 9.7× (11.35%)
Jun 2026 10.9× (6.33%)
Mar 2026 11.7× 8.35%
Dec 2025 10.8× (3.22%)
28 more quarters

Against its own ten years

Low 0.0× High 46.3×
Ten-year median 13.2×
Current reading's percentile 20

EV/EBITDA against peers

Company EV/EBITDA
PLSE Pulse Biosciences, Inc compare n/m
MMED MiniMed Group, Inc. compare n/m
NVST Envista Holdings Corporation 10.3×
STVN Stevanato Group S.p.A. compare 11.3×
MMSI Merit Medical Systems, Inc. compare 15.5×
ICUI ICU Medical, Inc. compare 16.0×
TFX Teleflex Incorporated compare 35.7×
WRBY Warby Parker Inc. compare 50.2×
ATRC AtriCure, Inc. compare 83.7×
Medical Instruments & Supplies industry median 14.9×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on NVST